The site of inhibin production in ovarian neoplasms

Histopathology

Volumn 29, Issue 5, 1996, Pages 465-468

  Flemming, P ^a   Grothe, W ^a   Maschek, H ^a   Petry, K U ^a   Wellmann, A ^b   Georgii, A ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Inhibin; Ovarian neoplasms; Sex cord stromal tumours

Indexed keywords

INHIBIN;

ARTICLE; CONTROLLED STUDY; FEMALE; GRANULOSA CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY METASTASIS; OVARY TUMOR; PRIORITY JOURNAL; SEX CORD TUMOR; STROMA;

EID: 0029846322     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1996.d01-511.x     Document Type: Article

References (17)

1. Yamoto M, Minami S, Nakano R, Kobayashi M. Immunohistochemical localization of inhibin/activin subunits in human ovarian follicles during the menstrual cycle. J. Clin. Endocrinol. Metabol. 1991; 74; 989-993.
2. Lappöhn RE, Burger HG, Bouma J et al. Inhibin as a marker for granulosa cell tumors. N. Engl. J. Med. 1989; 321; 790-793.
3. Cooke I, O'Brien M, Charnock FM, Groome N, Ganesan TS. Inhibin as a marker for ovarian cancer. Br. J. Cancer. 1995; 71; 1046-1050.
4. Healy DL, Burger HG, Mamers P et al. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. N. Engl. J. Med. 1995; 329; 1539-1542.
5. Flemming P, Wellmann A, Maschek H, Lang H, Georgii A. Monoclonal antibodies against inhibin represent key-markers of adult granulosa cell tumors of the ovary even in their metastases. Am.J. Surg. Pathol. 1995; 19; 927-933.
6. Scully RE. WHO classification and nomenclature of ovarian cancer. J. Natl. Cancer Inst. Monogr. 1975; 42; 5-7.
7. Grootenhuis AJ, van Sluis FJ, Klaij IA et al. Inhibin, gonadotrophins and sex steroids in dogs with Sertoli cell tumors. J. Endocrinol. 1990; 127; 235-242.
8. Ohashi M, Hasegawa J, Haji M, Igarashi M, Nawara H. Production of immunoreactive inhibin by a virilizing ovarian tumor (Sertoli-Leydig tumour). Clin. Endocrinol. 1990; 33; 613-618.
9. Risbridger GP, Clements J, Robertson DM et al. Immuno- and bioactive inhibin and inhibin-alpha-subunit expression in rat Leydig-cell cultures. Mol. Cell. Endocrinol. 1989; 66; 119-122.
10. Gustafson ML, Lee MM, Scully RE et al. Mullerian inhibiting substance as a marker for ovarian sex-cord tumor. N. Engl. J. Med. 1992; 326; 466-471.
11. Yamoto M, Minami S, Nakano R. Immunohistochemical localization of inhibin subunits in polycystic ovary. J. Clin. Endocrinol. Metabol. 1993; 77; 859-862.
12. Blaakaer J, Micic S, Morris ID et al. Immunoreactive inhibin-production in postmenopausal women with malignant epithelial ovarian tumors. Eur. J. Obstet. Gynecol. Reprod. Biol. 1993; 52; 105-10.
13. Morris JM, Scully RE. Endocrine Pathology of the Ovary. St. Louis: CV Mosby Co. 1958; 131-139.
14. Heinonen P, Koivula T, Rajaniemi H, Pystynen P. Peripheral and ovarian venous concentrations of steroid and gonadotropin hormones in postmenopausal women with epithelial ovarian tumors. Gynecol. Oncol. 1986; 25; 1-10.
15. Matzuk MM, Finegold MJ, Su JJG, Hsueh AJ, Bradley A. Alpha-inhibin is a tumour suppressor gene with gonadal specificity in mice. Nature 1992; 360; 313-319.
16. Knight PG, Muttakrishna M. Measurement of dimeric inhibin using a modified two-site immunoradiometric assay specific for oxidized (Met O) inhibin. J. Endocrinol. 1994; 141; 417-425.
17. Groome NP, Illingworth PJ, O'Brien M et al. Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clin. Endocrinol. 1994; 40; 717-723.